Seeking Alpha

Boston Scientific Corp. (BSX)

()

Instablog posts on BSX

  • Viking Systems: Undervalued and Breaking New Ground (OTC:VKNG) by M. E. Garza
    It's rare to find a profitable small cap biotech company, much less one that has been flying under the radar screen and has so many positive features that can help propel its share price upward quickly. We have uncovered one that meets those requirements and then some. The company even has a... More »
    November 15, 2009 • IMGG.OB, ISRG, BSX
  • (?) AGAM priced 37.5% under original range mid-point by IPOdesktop
    The underwriters totally misestimated the pricing, probably because of pressure from selling shareholders.Very unusual to have price decrease, pre-IPO & have the selling shareholders up their number of shares by almost 40%.read more in IPO report, adjusted for IPO price of... More »
    October 21, 2009 • AGAM, BSX, STJ
  • C.R Bard (BCR) by Peter Mycroft Psaras
    The Following shows the year end prices for the last 24 years (except 2009) for one of my favorite stocks, C.R. Bard (BCR). A $10,000 investment in BCR in 1985 would be worth $573,037 today for a total return on your investment of 5,630%.  BCR has also returned an average annual return of... More »
    October 19, 2009 • STJ, BSX, JNJ
  • AGA Medical (AGAM) IPO expected this week, $960mm market cap by IPOdesktop
    Scheduled to price $275mm Tuesday, trade Wednesday, Oct 21. High 82% gross margin. Declining net income. Shows loss for six months ended June 30. Highly leveraged (too much debt)Read more http://www.gaskinsco.com/linkto-aga.shtml More »
    October 19, 2009 • BSX, STJ, JNJ
  • Time to earn.. by Nojus
    It’s time for quarterly companies’ earnings and revenue reports now. So we see a consolidation period in the market.  There will be good and bad results. We are waiting too and looking for trading ideas. There no important movement in DJIA yesterday – waiting mode. But... More »
    October 8, 2009 • AA, BSX, NDN
  • Portfolio and ideas by Nojus
     DIJA index hits upper trend line. So we are realizing it as a return to up trend. But we have a worry about momentum declining. Better to say, there is an optimism in the market, but we accept it with some kind if calmness.     BSX gave another chance to buy its stocks more... More »
    October 7, 2009 • BSX, NDN
  • My portfolio by Nojus
    Stocks rallied and Dow closes up 110 points yesterday. But some of my positions closed at stop loss: ANX and CTIC. DJIA rebounds from lower trend line. I remarked about stronger buyers yesterday. It seems it’s truth. But it’s too early say about UP trend recovering:     LGF... More »
    October 6, 2009 • ANX, CTIC, LGF
  • Want To See John Paulson's Portfolio? by YCHARTS.com
    John anticipated the subprime mortgage melt-down in 2007 and reaped the rewards but now he is buying the banks.  Should you?As many investors know, John’s firm has to disclose all of their holding in quarterly filings with the SEC.  13F Filings are a great way to find... More »
    September 1, 2009 • T, BAC, AU
  • St. Jude Medical Might Benefit from Positive Merck and Boston Scientific Earnings by David Ristau
    The Oxen Group is liking the prospects for St. Jude Medical Inc. (STJ) for Monday. The market is definitely going to be decided by tomorrow morning's earnings reports, so this recommendation is preliminary with an update to be posted tomorrow morning about exactly what we think will happen. St.... More »
    July 21, 2009 • STJ, MRK, BSX
  • FDA Calendar Updates: ACUR, BSX, GSK, JAV, KG, SNTS by Mike Havrilla
    Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch... More »
    June 23, 2009 • ACUR, KG, BSX

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.